Innovation Research Fellow, Faculty of Medicine & Health Sciences
Shaun Robertson completed his BSc at the Aberdeen University in 2008, followed by a MSc in 2009. Undertaking a Knowledge Transfer Partnership (KTP) associate position at the University of Aberdeen and NovaBiotics Ltd. He undertook his PhD in microbiology at the University of the West of Scotland (2012 -2016) followed by Post-Doctoral research position, aiding in the continued development of a nanovibrational bioreactor at UWS and the University of Strathclyde.
Shaun is a Research Fellow at the University of Nottingham for NBIC. Shaun's area of research focuses on the development of polymicrobial biofilms models and understanding the interplay between microbes present in these biofilms. His research also covers the testing of novel compounds.
Shaun is actively engaged with STEM activities and public engagement as a registered STEM ambassador, since 2014. This culminated in summer 2016 with an exhibition at the Royal Society Summer exhibition in London, which saw 14,500 members of the public and fellows of the Royal Society engage with the exhibition.
Shaun's research focuses on the development of polymicrobial biofilm models as part of the National Biofilm Innovation centre (NBIC). He also has a strong interest in antimicrobial drug discovery and… read more
Shaun's research focuses on the development of polymicrobial biofilm models as part of the National Biofilm Innovation centre (NBIC). He also has a strong interest in antimicrobial drug discovery and development of antimicrobial coatings.
Shaun's past research focused on the response of bacteria to nanovibrational stimulation and it's effect on biofilm formation. He also co-developed novel antimicrobial diamond like-carbon coatings which were produced using a plasma enhanced chemical vapour deposition system. During his first post-doctoral post he undertook the continued development of a novel nanovibrational bioreactor and bespoke custom cultureware.
My future research focuses on the identification of biomarkers of microbial infection, through to clinical validation and translation to application through the appropriate comercialisation pathway.
University of NottinghamMedical School Queen's Medical CentreNottingham NG7 2UH
Contact us